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Cellular regulation of the uterine
microenvironment that enables
embryo implantation
Ana Claudia Zenclussen1* and Günter J. Hämmerling2
1 Experimental Obstetrics and Gynecology, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany, 2 Molecular
Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany
Implantation of the fertilized egg into the maternal uterus is a crucial step in pregnancy
establishment. Increasing evidence suggests that its success depends on various cell
types of the innate immune system and on the fine balance between inflammatory and
anti-inflammatory processes. In addition, it has recently been established that regulatory
T cells play a superordinate role in dictating the quality of uterine environment required for
successful pregnancy. Here, we discuss the cellular regulation of uterine receptivity with
emphasis on the function and regulation of cells from the innate and adaptive immune
system.
Keywords: uterine environment, Treg cells, mast cells, uterine NK cells, macrophages, uterine DCs, neutrophils,
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Introduction
Pregnancy begins with the fertilization of the ovum, followed by implantation of the blastocyst in
the maternal uterus. To implant, the blastocyst needs to aggressively adhere to the endometrium so
that it can be provided with oxygen and nutrients. During this process, uterine tissue remodeling
and inflammatory processes are required. After successful implantation, specific tolerance toward
foreign paternal fetal antigens needs to be established (1)without loss of the ability to fight infections.
Much effort has been invested into the identification of the tolerance pathways responsible for
smooth development of pregnancy. Maternal CD4+CD25+ Foxp3+ regulatory T cells (Tregs) are
the most studied cells in this regard. They have been reported to contribute to the maintenance of
tolerance during pregnancy by suppressingmaternal alloreactive immune responses against paternal
antigens in fetal cells (2–5). However, recent data showed that their participation at initial stages of
pregnancy, e.g., implantation, may be much more relevant than at later stages when alloreactivity
against the fetus needs to be prevented. Animals depleted of Foxp3+ Tregs presented impaired
implantation in both, allogeneic and syngeneic matings, and their uterine characteristics reminded
those of animals that were infected with Chlamydia and thus exhibited limited success of pregnancy
(6). These observations lead us to propose that there is an important albeit unspecific role for cells
of the adaptive immune system even at the time of implantation, when inflammatory processes and
innate cell populations reportedly play an important role.WhenTregs are deleted at later time points,
pregnancy is much less jeopardized as some fetuses survive the temporary Treg absence [(3, 4) and
unpublished data from Teles and Zenclussen]. Similarly, infertile patients have critically diminished
Foxp3 mRNA levels in endometrium, supporting the concept of Foxp3+ Treg importance for
pregnancy establishment (7). In our own studies, we observed that Foxp3+ Tregs are essential for
implantation via modulation of the uterine microenvironment. In their absence, inflammation and
fibrosis occur and blastocysts fail to implant. However, Tregs are not the only cells of relevance for
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implantation. In this review, we will dissect data available on dif-
ferent cell populations of both the innate and the adaptive immune
system, and discuss the complex cellular and molecular network
in the uterinemicroenvironment that favors implantation.Wewill
address both mouse and human data, as it is important to learn
whether data obtained in complex animal systems are relevant for
the human beings. In view of the relevance of the topic for couples
with infertility or subfertility, we will further discuss potential
ways to positively modulate the uterine environment, thereby
allowing a better implantation rate. In particular, data obtained in
mice emerge as very informative for human pregnancies, which
is most probably due to the fact that both species present hemo-
chorionic placentation (8), and to the similarities of their immune
systems.
KEY CONCEPTS
(1) A perfectly coordinated interplay between immune cells, hormones, and
cytokines is crucial during peri-implantation. This can be greatly affected
by environmental factors.
(2) Cells of the innate immune system are present at the uterus at fecun-
dation and their presence is fundamental to initiate tissue remodeling
that ensures implantation and later to support the adaptation of maternal
spiral arteries.
(3) From the adaptive immune system, regulatory T cells emerge as critical
for early pregnancy establishment. Their absence provokes inflammation
and fibrosis in the uterus, which hampers implantation.
(4) Perturbations in the uterus, e.g., by removal of a particular cell popu-
lation when using a mouse model, greatly affect the establishment of
pregnancy. This is clinical relevant and goes in hand with observations
done in infertile patients.
Uterine Microenvironment During
Peri-Implantation
During the period of periconception, the blastocyst is formed
while the uterus prepares for implantation. For this to occur,
a finely orchestrated balance of cells and soluble mediators is
necessary. While genetic factors are relevant for the quality and
viability of the blastocyst, the immune and endocrine systems are
responsible for the formation of a perfect environment where the
blastocyst, and later the embryo and fetus, will grow and develop
into a healthy baby. For implantation to occur, it is necessary to
have a receptive endometrium, a so-called healthy uterine milieu
that allows the invasion of the blastocyst and the rapid growth of
the placenta while supporting the transformation of uterine into
decidual cells. This is facilitated by immune cell populations, the
cytokines they secrete and, importantly, by hormonal changes.
The immune cells that are relevant for implantation are present
already before pregnancy. Immune cells that are present in the
uterus usually display a unique, uterine phenotype that differs
from the phenotype of their counterparts located either in the
periphery or in other tissues. The unique phenotypes and possibly
unique functional properties are likely provoked by the particular
environment conditions that modify the cells and make them sui
generis for a particular tissue. Themost intensively studied uterine
immune cells are the uterine natural killer cells (uNK cells) (9).
Uterine dendritic cells (uDCs) also show a unique phenotype as
well as demonstrated in both human beings and mice (10, 11).
They are present in high numbers at specific sites along the non-
pregnant uterus as shown in vivo (12). The same is true for uterine
mast cells (uMCs) that differ enormously from MCs found in
other tissues (13, 14), and for uterinemacrophages that are crucial
in modulating later trophoblast function (15). Some immune cells
present in the uterus fluctuate in number through the different
phases of the menstrual cycle in human beings or the estrus cycle
in mice. This is true for uNK cells (16), macrophages (17), and
Treg (6). These oscillations are probably mediated by hormonal
changes (18). Other cells are likely to be attracted from the periph-
ery to the uterus upon hormonal changes in early pregnancy
as shown for uMCs (19) and macrophages (17). For other cells,
e.g., uDCs, it is still unclear whether they reside in the uterus or
are attracted by pregnancy hormones or both. From our in vivo
microscopy data, uDCs are likely localized in the uterus at strate-
gic niches that may indicate the future sites of implantation (12).
Immediately after copulation, the presence of seminal fluid
attracts innate and adaptive immune cells due to the fact that
seminal fluid can rapidly activate cytokine secretion (20). This
is true for several animal species and has been most studied in
mouse models. In the human cervix, Sharkey et al. (21) could
show that the presence of seminal fluid after coitus attracts
macrophages, dendritic cells (DCs), and T cells (21). In animal
models, the specific depletion of macrophages, DCs, and mast
cells (MCs) impairs implantation (13, 22, 23). Likewise, specific
depletion of Tregs before implantation negatively affects the
uterine environment and hinders implantation (6). Interestingly,
human infertile women have very low levels of endometrial
Foxp3, supporting the relevance of Tregs for implantation (7).
Thus, the presence of crucial cells and the influx of new ones
at peri-implantation dictate its success. This is, in turn, greatly
affected by environmental factors such as nutritional state and
medication. Excessive lipid storage in obese mice causes disorders
of ovarian function that leads to follicular atresia (24). In addition,
diet-induced obesity negatively affects uterine cells populations
such as uNK cells (25). In a recent study, Bellver and colleagues
reported that obesity in women impairs the reproductive outcome
of ovum donation because of reduced uterine receptivity (26). A
possible explanation for poor uterine receptivity in obese patients
may be an aberrant Adipoq signaling in decidual cells leading to
suboptimal decidualization (27). Hence, a perfectly coordinated
interplay between immune cells, hormones, and cytokines is
crucial during peri-implantation, and this can be greatly affected
by environmental factors.
Cells of the Innate Immune System in the
Uterus and Their Relevance for
Implantation
In general, cells of the innate immune system are the first to
encounter microbes and foreign antigens; they recruit other cells
by releasing chemokines and cytokines, and they activate the
adaptive immune system so that an antigen-specific immune
response can be initiated. In addition to acting as the first line
of defense, cells of the innate immune system that are present
in the uterus have an additional role. They actively contribute to
pregnancy establishment either by modulating tissue remodeling
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or by releasing angiogenic factors that contribute to spiral artery
(SA) remodeling. In addition, their activation status and cytokines
dictate the uterine environment.
Macrophages
Macrophages are abundant in the uterus. The numbers fluctuate
during the estrus cycle (28), which is driven by estrogen and
progesterone as shown in ovariectomized mice (17). Immedi-
ately after copulation, more macrophages are attracted to the
endometrium by seminal fluid (29). Macrophages are present
in tissues from early pregnancy losses but this is most proba-
bly a consequence and not a cause for pregnancy failure (30).
Decidual macrophages are activated (31) and therefore able to
present antigens toT cells. They have a cytokine profile resembling
M2 macrophages that are programed into a immunosuppressive
phenotype and secrete transforming growth factor (TGF)-beta
and interleukin-10 [IL-10 (32, 33)]. They further produce other
tolerance-related molecules such as indoleamine 2,3 dioxygenase
[IDO (34)]. Macrophages were reported to modulate trophoblast
function in vitro. Fest et al. showed that trophoblasts actively
recruit monocytes to produce cytokines that in turn will support
their own survival (15). Leukemia inhibitory factor (LIF) deficient
mice are infertile because of implantation failure, but pregnancy
can be rescued by LIF administration at day 4 of pregnancy (35).
Lif knockout mice that were mated were investigated for their cell
populations at early pregnancy without LIF application in order
to delineate the cellular changes that are associated with failed
implantation. Macrophages were reduced in numbers by more
than half in LIF knockout vs. wild-type mice (36). This observa-
tion indicates a role for macrophages in implantation. More evi-
dence for the importance of macrophages was recently provided
by Sarah Robertson’s group. Care and colleagues reported that
specific depletion ofCD11bmacrophages resulted in implantation
failure, owing to the fact that macrophage depletion altered the
luteal microvascular network that is necessary for the integrity of
the corpus luteum and progesterone production (22). This finding
may explain the subfertility of women with luteal insufficiency.
Recently, the location and density of macrophages in human
implantation specimens was studied in vitro. At first trimester
placentation sites, a higher density of decidual macrophages
was found in close proximity to the invasive trophoblast (37),
which supports the pioneering findings from Fest et al. (15),
who reported that the interaction with trophoblasts modifies
the phenotype of macrophages. Indeed, decidual macrophages
were postulated to contribute to trophoblast invasion and pla-
centa development (34). In pregnancy pathologies, levels of
macrophage-associated molecules are reportedly diminished,
e.g., granulocyte-macrophage colony-stimulating factor [GMCSF
(38)]. In human beings, CD163high endometrial macrophages
constitutively secrete both pro- and anti-inflammatory cytokines
and pro-angiogenic factors (39). Recently, Siwetz et al. reported
that the addition of fractalkine significantly impaired the abil-
ity of monocytes to adhere to trophoblasts (40). Fractalkine is
upregulated in pregnancy pathologies such as chorioamnitis (41)
suggesting that in pregnancy pathologies, the communication
between trophoblasts and monocytes may be disturbed. These
observations point also to the relevance of macrophages inhuman
pregnancies.
Neutrophils
Neutrophils are short-lived and function as effector cells. In
general, they do not reside in tissues but are recruited from
the circulation to the sites where they are needed, usually to
sites of inflammation or infection (42). Tissue infiltrating neu-
trophils can have angiogenic properties and have a role in the
late stages of tumor progression through enhancement of angio-
genesis and vascular remodeling (43). This is similar to what is
known about M2 tumor-associated macrophages (44). Recently,
two tumor-associated neutrophil populations were identified:
N1 antitumorigenic neutrophils, with cytotoxic and immune
stimulatory potential; and N2 protumorigenic neutrophils, with
immunosuppressive and angiogenic properties, but lacking cyto-
toxic potential (45). Interestingly, tissue resident neutrophils
in non-pregnant human fallopian tubes are less cytotoxic than
peripheral blood neutrophils (PMNs) and exhibit higher cytokine
production, particularly of vascular endothelial growth factor
(VEGF) (46). Amsalem and colleagues recently described a novel
population of second-trimester decidual neutrophils (dNs) (47).
Under the influence of the decidual microenvironment, mainly
of decidual CXC-motiv-chemokine (CXCL8), these cells adopt a
unique phenotype that is different from the phenotype of PMNs,
similar to dNK cells, decidual macrophages, and uNK cells. The
data suggest that this population displays angiogenic properties.
The authors also observed the presence of this population in
mice. In both human and mice samples, these cells were spatially
restricted to the decidua basalis (DB). When compared to PMNs,
the dNs expressed high levels of neutrophil activationmarkers and
angiogenesis-related proteins such as VEGF, Arginase-1 (ARG-1),
and chemokine ligand (CCL)2 (47). Functional in vitro assays
showed that supernatants from second-trimester human decidua
stimulated transendothelial PMN invasion, upregulated VEGF,
ARG1, CCL2, and intercellular adhesion molecule (ICAM)1
mRNA levels, and increased PMN-driven in vitro angiogenesis in
a CXCL8-dependent manner (47).
Contrary to this positive function, recent studies by Mizugishi
and collaborators suggest that excessive number of neutrophils is
pregnancy deleterious. These authors showed that the disruption
of the sphingosine kinase gene (Sphk) during pregnancy causes
an upregulation of CXCL1 and CXCL2 in the decidua that in turn
provokes a massive influx of neutrophils into the feto-maternal
interface with enhanced oxidative damage, resulting in early fetal
death (48). Sphk-deficient mice exhibit neutrophilia in peripheral
blood and a decrease in the number of decidual natural killer cells.
The blockage of neutrophil influx protected Sphk-deficient mice
against pregnancy loss (48). Specific depletion of neutrophils in
mouse models and functional studies with dNs will help in the
future to understand their role in implantation and pregnancy.
Dendritic Cells
An important function of DCs is the presentation of antigens
to T cells. This step is also relevant in pregnancy as the nature
of antigen presentation defines the fate and the quality of the
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immune response that will lead to tolerance or rejection of the
blastocyst. Our data obtained in mouse models strongly suggest
that the first encounter between male antigens present in the
sperm and maternal DCs takes place in the vaginal lumen imme-
diately after copulation (49). This is in agreement with a number
of reports indicating that also in human beings seminal fluid
containing male antigens attracts maternal immune cells such as
DCs (21, 50). In mice, DCs are also located in the endometrial
tissuewhen the female is sexually receptive (51).We could observe
that DCs are very abundant in murine uterus during estrus, thus
at sexual receptivity (12). Because only low numbers of DCs could
be isolated from the uterus, it was believed that they were present
only in low density. However, by employing in vivo microscopy,
we could demonstrate that DCs are abundant in the uterus. More-
over, uDCs are located in cluster-like structures along the uterus
may indicate the future sites of implantation (12). Like uterine
macrophages, neutrophils, dNKs, and uMCs, uDCs diplay a dis-
tinctive phenotype compared with circulating DCs or DCs resi-
dent in other tissues. DC-SIGN+CD14+CD83  DCs found in
the uterus represent a unique subpopulation capable of activating
inducible Tregs (52).We found heme oxygenase-1 (HO-1) and the
pregnancy molecule human chorionic gonadotropin (hCG) to be
important modulators of uDC maturation state, both implied in
theirmaintenance as immature tolerogenicDCs (53, 54). GM-CSF
is also an important regulator of DCmaturity, and similar to hCG
and HO-1, it confers DCs an immature phenotype (55). Recently,
Du et al. (56) showed that DCs are involved in the communication
between trophoblasts and decidual Tregs. Negishi et al. recently
showed that the depletion of 33D1(+) DCs during the perinatal
period caused substantial fetal loss mediated by IL-12. These
findings show the importance of balancing DC subsets during
pregnancy. Interestingly, progesterone could rescue the abortions,
highlighting the role of hormones in the balance of the pregnancy
immune response (57).
The importance of DCs for pregnancy establishment was also
suggested by Plaks and colleagues who observed in CD11c.DTR
mice that animals depleted of DCs were unable to implant and
that this failure was related with their ability to modulate uter-
ine receptivity. DCs emerge as important cells for uterine tissue
remodeling and angiogenesis (23). Whether mice that are consti-
tutively devoid of DCs (58) have impaired fertility or suboptimal
pregnancies has not been studied. So far, it seems that depleting
DCs disrupts uterine integrity and this interferes with implan-
tation. In human beings, DCs of an immature, and thus tolero-
genic phenotype, are present and abundant in the endometrium
and seem not to fluctuate throughout the menstrual cycle (59).
They are also present in the decidua of early pregnant women
(60). Human decidual DCs from early pregnancy express the
tolerogenic markers IL-10, human leukocyte antigen (HLA)-G,
and leukocyte immunoglobulin-like receptor subfamily B mem-
ber 2 [LILRB2; (61)]. It was observed that the proportion of the
described decidual DC-SIGN+ cells (10) was significantly lower
in samples from miscarriages when compared to samples from
women with normal pregnancies (62). As in mice, it seems that
the balancing of DC subsets is relevant for pregnancy mainte-
nance and that severalmolecules,most prominently cytokines and
hormones, are involved in keeping this balance.
Uterine Mast Cells
Mast cells are present in the female reproductive tract (63–65).
Until recently, their contribution to pregnancy establishment
and/or maintenance was unclear as contradictory reports could
be found in the literature. In pregnant rats, MC degranulation
was shown to have positive effects on cervical angiogenesis (66).
In mice, Menzies et al. found no role for these cells in labor
in a syngeneic context when employing C57BL/6J-KitW-sh/W-sh
mice (67). We recently reported that, in adult female mice, a
transient population of MCs appears cyclically within the uterine
endometrium (13). As described for other cells of the innate
immune system, uMCs represent a different population of MCs
compared to MCs found in other tissues. uMCs are a mixed pop-
ulation of connective tissue-type MCs, mucosal MCs, and a tran-
sitional type that share features of both MC types. They express
CD117 and Fc"RIα, while only a small population expresses
Mcpt5 and Mcpt8 (13). uMCs peak in number at the fertile phase
of the murine estrous cycle (13). They remain high in numbers
if pregnancy establishes. By using in vivo microscopy, we could
confirm that uMCs are present in abundance in the uterus of
pregnant C57BL/6J Mcpt5-Cre ROSA26-EYFP mice (14). They
are localized in close proximity to blood vessels (13, 14). This
is likely regulated by endocrine mechanisms. Indeed, estradiol is
able to potentiate MC degranulation in vitro (68). We recently
found that estradiol and progesterone promote MC migration
from the periphery to the uterus of ovariectomizedmice and favor
subsequent maturation of these cells in situ (19). KitW-sh/W-sh mice
lacking MCs were described as “fertile” (69); however, KitW-sh/W-sh
colonies often show irregular birth rates and high natal and
postnatal death rates. We observed that in allogeneic, clinically
relevant pregnancies, MC-devoid KitW-sh/W-sh female mice dis-
played severely impaired implantation, although single females
presented normal litter sizes (13). The transfer of wild-type bone
marrow-derivedMCs (BMMCs) was able to completely rescue the
phenotype (13). These findings support the positive role of MCs
in normal implantation. In our model, transferred MCs migrated
to the fetal–maternal interface and the local injection of these
cells could also recapitulate a normal phenotype (13). Hence,MCs
act locally within the uterus to foster normal pregnancy. MC-
chymases were present after adoptive or local BMMCs transfer.
Because chymases contribute to matrix degradation and tissue
remodeling and induce sprouting of new blood vessels (70), we
hypothesized that MCs are important initiators of tissue remod-
eling during pregnancy. Indeed, other studies in rat showed that
the pro-angiogenic process that takes place in the uterine cervix
during rat implantation is regulated by the pro-angiogenic factor
VEGF-A released by MCs upon degranulation (66, 71). Besides
fostering implantation, we found that uMCs are involved in SA
remodeling in later pregnancy (13). MC-deficient mice presented
abnormally remodeled SA and the transfer of BMMCs could
revert this phenotype (13). The glycan-binding protein galectin-
1 (Gal-1) seems to participate in this process as the transfer of
Lgals1 /  BMMCs was unable to normalize pregnancy outcome
(13). Thus, uMCs are important cellular players that support tissue
remodeling during implantation, and later positively influence
angiogenesis (66), placentation, and fetal growth (13). Hence, like
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other cells of the innate immune system, MCs that are present in
the uterus are phenotypically different fromMCs residing in other
tissues and contribute to pregnancy establishment. Whether or
not this finding reflects also the situation in pregnant women is
unknown.
Uterine Natural Killer Cells
Uterine natural killer cells represent the major immune cell popu-
lation at the early feto-maternal interface; they are key regulators
of the maternal uterine vasculature remodeling (72). As for other
innate immune cells, uNK cells greatly differ in phenotype and
function from peripheral NK cells. Similar to uMCs, they are also
localized close to vessels in the DB and the mesometrial lymphoid
aggregate of pregnancy (MLAp) (73, 74). CD3 CD122+ uNK
cells do not express the common NK markers NK1.1 and DX5,
but bind selectively and specifically to the lectin Dolichos biflorus
agglutin (DBA) (75). Besides production of pro-angiogenic factors
VEGF (76), placental growth factor (PGF) (77), and Delta-like
ligand (78), mouse uNK cells secrete local interferon (IFN)-γ that
is necessary and sufficient for the initiation of SA remodeling
(79). Mice devoid of uNK cells, like IL-15 KO mice that do
not have NKs or uNK cells, have impaired SA modification and
placenta development, resulting in intrauterine growth restriction
(IUGR) and smaller progeny (80), but it has to be kept in mind
that in addition to NK deficiency IL-15 KO mice display other
impairments, whichmay affect pregnancy. In human beings, uNK
numbers fluctuate during the menstrual cycle (16) but in mice
they are present in comparable numbers throughout the estrous
cycle and expand only if pregnancy takes place (81).We found that
HO-1 and its metabolite carbon monoxide (CO) are important
modulators of uNK cell number. HO-1 deficient animals show
a significant reduction in the absolute number of uNK cells as
early as gestation day 8 (82); these findings are in agreement with
observations by Zhao et al (83). We postulated that the absence of
HO-1 interferes with the phenotype of macrophages (M1 rather
than M2) that in turns provokes less IL-15 secretion, thereby
reducing uNK cell numbers (81). HO-1 deficiency resulted not
only in fewer uNK cells but also in shallow SA remodeling and
IUGR (82). The administration of CO from gestation day 3 until
day 8 provoked a significant increase in the number of uNK cells
at the feto-maternal interface that was independent of IL-15 (82).
CO treatment rather provoked the in situ proliferation of uNK
cells (82). Furthermore, CO application to pregnant Hmox1+= 
females enhanced the expression of VEGF, PGF, and IFN-γ that
accompanied SA reshaping. In a more clinically relevant aspect,
it was shown that CO application during early pregnancy can
actually prevent hypertension and IUGR in HO-1-deficient mice
(82). The importance of themicroenvironment at early pregnancy
and the relevance of immune cells, in particular of uNK cells, are
highlighted by these experiments. In HO-1-deficient animals, the
rise in the blood pressure began at day 14 while the CO treatment
that could prevent it was performed between days 3 and 8 of
pregnancy. Hence, the events leading to gestational hypertension
are triggered and can be corrected beginning as early as day 3 in
themouse. One important hallmark of the blood pressure normal-
ization is the expansion of uNK cells and changes in angiogenesis
at the feto-maternal interface. In human beings, a shallow invasion
of the trophoblast at week 14, long before pre-eclampsia symptoms
arise in patients, is responsible for the pathophysiology of this
complex disease (84). These observations illuminate the relevance
of a balanced microenvironment and the importance of special-
ized cells of the innate immune system. Contradictory data can
be found in the literature regarding uNK cell function in human
beings, and more studies are needed to elucidate their function
and regulation.
Cells of the Adaptive Immune System in
Early Pregnancy Success
Contrary to the original hypothesis from Peter Medawar in the
1950s, it is known that the maternal immune system is not igno-
rant but aware of the growing conceptus. In this context, it is
important to note that trophoblasts have reduced antigenicity
and attenuated expression ofmolecular histocompatibility (MHC)
genes, but transplantation antigens are clearly expressed (85).
Moreover, owing to the bidirectional cell trafficking between
mother and fetus antigen presentation and recognition can take
place anywhere in the maternal immune system. This recognition
needs to induce tolerancemechanisms so that the fetus is tolerated
and not rejected by classical immune mechanisms. We found that
paternal antigens are present in several immune and non-immune
maternal organs during the whole period of pregnancy. The first
place of encounter of paternal antigens is the vaginal lumen, where
maternal DCs meet paternal antigens present in seminal fluid
(6, 49). Antigens present in sperm and in particular in seminal
fluid are sufficient to elicit an expansion of a particular T cell
type: Tregs. Femalesmatedwith vasectomizedmales present levels
of Tregs comparable with females mated with intact male; the
mating of females with males whose seminal vesicles had been
previously removed was associated with a lack of Treg expansion
in the periphery and in paraaortic lymph nodes (6, 86). T cells that
are reactive for paternal/fetal antigens are detectable in peripheral
blood and decidua of healthy pregnant women (87). Mice with
transgenic T cells that react to fetal antigens are present and
functional since early pregnancy (55). Hence, maternal T cells are
crucial in recognizing and tolerating the invading fetus (1). No
information is available about the participation of B cells at the
early stage blastocyst implantation. We have reported, however,
that failure of IL-10 producing B cells to expand is related with
miscarriages. In vitro, these cells were able to hamper tumor
necrosis factor (TNF)-alpha production by effector T cells (88).
In mice, early transfer of IL-10 producing B cells can rescue from
immunological abortion (89). Whether this is related to events
taking place in early pregnancy is unknown. Because B cell func-
tionally can bemodified by pregnancy hormones [reviewed inRef.
(90)], it is assumed that they are also implied in early pregnancy
and future studies will reveal their importance.
Regulatory T Cells
Much effort has been devoted to the understanding of the role of
cells and molecules involved in generation and maintenance of
tolerance that guarantees pregnancy success. Even though initial
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studies concentrated on T helper cells able to produce either
Th1 or Th2 cytokines, it is now clear that a more specialized
subset of T cells with regulatory function is the main regulator
of specific immunosuppression. These cells are Tregs. Tregs are
crucial players in the avoidance of autoimmunity, and their role
in physiological and pathological processes has been studied since
their discovery in 1995 (91). There is consensus that Tregs are
relevant for pregnancy. Pioneering studies from Aluvihare and
colleagues (92) and our own laboratory in 2005 (2) revealed their
pivotal role for pregnancy success.
We have recently reported that, in vaginal lavage, Tregs peak
at the receptive phase of the estrous cycle, namely estrus. In vivo
2-photon microscopy in Foxp3gfp animals impressively demon-
strated a clustering of Tregs in uterine tissue during estrus
that was not observed during the other phases of the oestrus
cycle (6). These data can be interpreted as a preparation of the
uterus for pregnancy and, therefore, show similarities with the
cycle-dependent expansion of innate immune cells in the uterus
(12, 13, 22).When compared to virginmice, an expansion of Tregs
was observed in the uterine draining lymph nodes from females
paired with intact or vasectomized males, whereas no expansion
was found in females mated with seminal vesicle-deficient males.
These data demonstrate the proliferative effect of seminal fluid on
Tregs in vivo. These results could be reproduced in vitro where
we could additionally show that Treg proliferation is inhibited
by anti-TGF β antibody (6). Thus, the uterine accumulation of
Tregs at sexual receptivity is followed by an expansion triggered
by seminal fluid, most likely by TGF-β contained herein. These
observations are in accordance with data from Robertson’s group
(93). Hence, Treg presence at the moment of pairing and their
further expansion by paternal components imply a role in implan-
tation. To further address these findings, Foxp3+ Tregs were
depleted in Foxp3DTR (94) mice by application of human diphteria
toxin (DT). Treg depletion beginning at d-9 in Foxp3DTR mice
provoked a failure of the embryos to implant, whereas PBS- and
DT-treated control mice displayed normal implantation (6). In a
second set of experiments, Tregs were depleted in BAC transgenic
Foxp3.LuciDTR mice (95) in syngeneic and allogeneic matings.
Treg ablation from d-2 to d5 resulted in severely impaired implan-
tation not only in biologically relevant allogeneic pregnancies
but also in syngeneic matings (6). At this early time point, the
most important function of Tregs is probably the prevention of
pro-inflammatory events that may occur during implantation.
Without Tregs, inflammation may be too strong and hinder the
nidation of the embryo. Indeed, we observed that Treg depletion
resulted in accumulation of uterine CD8+ T cells and of activated
T cells in lymph nodes draining the uterus (6). Additionally, the
uterine tissue was inflamed and thickened after Treg depletion
treatment. The inflammatory mediators IL-15, IL-6, chemokine
receptor (CCR)5, CXCL11, CCL19, andCXCL3were upregulated,
and fibrosis could be detected in mice devoid of Tregs (6). Thus,
depletion of Tregs prior to mating leads to a hostile uterine
environment for implantation to take place, which is character-
ized by the occurrence of inflammation and fibrosis. A similar
scenario was observed in CCR7-deficient mice. The number of
CD4+Foxp3+ Treg in the uterus was drastically reduced in these
mice and, consistently, this resulted in implantation failure (6).
Thus, CCR7 mediates the homing of Treg to the uterus and
its absence hampers implantation. Interestingly, Guerin et al.
reported the presence of CCL19, the ligand for CCR7, in glandular
and luminal uterine epithelial cells (93). In mice, depletion of
Tregs or absence of Tregs in the uterus, as in CCR7-deficient
females, resulted in a dramatic impairment of implantation. It
can be speculated that CCR7/CCL19 are implied in the migration
of thymic Tregs to the uterus (as it is known for other tissues)
and that pregnancy-specific molecules support Treg migration
and/or expansion once fertilization takes place. Treg presence
before implantation emerges as important for the generation of an
adequate microenvironment so that the blastocyst can attach and
implant. In infertile women, Foxp3 is diminished in endometrium
(7). This would support our hypothesis. In mice that were specifi-
cally depleted from Tregs before pregnancy, we observed swollen
uteruses that presented no viable implantations. Pelvic inflamma-
tion, uterine swelling, and intraluminal occluding fibrosis of the
oviduct after infections with Chlamydia sp. are often associated
with infertility (96, 97). It seems that without Tregs, inflammation
overcomes and favors a rather hostile uterine microenvironment
that hinders the nidation of the embryo. The genetic ablation
of HO-1, which leads to inflammation too, is leading to failing
implantation as well (98). Thus, Tregs are pivotal for implantation
as they positivelymodulate the uterine environment that is needed
for nidation. In their absence, the communication between the
uterine tissue and the blastocysts is impaired, hindering the proper
implantation of the latter.
Contrary to previous assumptions, it seems that Tregs are rele-
vant for establishing rather than maintaining pregnancy. In our
own studies, depletion of Tregs during mid-pregnancy did not
interfere with its course (unpublished data). In another study,
Samstein et al. (4) employed the same Foxp3DTR knock in mice
used by us (94), in which DT application depletes more than
95% Tregs, and reported a modest resorption rate of 10% when
Tregs were ablated at d5.5 after the establishment of pregnancy.
Thus, pregnancy is not seriously jeopardized when Tregs are
depleted once implantation has taken place, although Tregs are
absolutely required for pregnancy to establish. However, there
are also conflicting reports in the literature. It was reported that
Treg ablation with anti-CD25 antibody at day 4.5 post conceptum
would result in a fetal absorption rate of about 50% in allogeneic
but not syngeneic matings, and that depletion at day 2.5 would
prevent implantation, again only in allo but not syngeneicmatings
(3). Since Foxp3.DTRmice aremore specific for Treg ablation and
deplete a much more efficiently than CD25 antibody, the latter
data may have to be regarded with caution.
Once pregnancy is established, additional and multiple mech-
anisms must exist to ensure maternal tolerance toward the fetus.
Several distinct tolerance mechanisms have been reported, such
as awareness of maternal T cells for paternal alloantigens and
acquisition of a transient state of tolerance during pregnancy
(1), ignorance of fetus-specific T cells, epigenetic silencing in
decidual tissue of chemokines that attract T cells (99), and other
mechanisms. Current studies concentrate on the pathways of
activation and proliferation of Tregs during early pregnancy. The
available studies agree that functional Tregs in sufficient numbers
are needed during peri-implantation. Several authors observed
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TABLE 1 | Available information about the function of innate and adaptive immune cells at early pregnancy.
Cell type Role Evidence Reference
INNATE IMMUNE SYSTEM
Macrophages Modulation of the initial immune response Antigen presentation at the feto-maternal
interface, secretion of tolerogenic factors
Renaud et al. (34)
Communication with trophoblasts Trophoblasts actively recruit monocytes and
modify their function
Fest et al. (15)
Important for implantation Specific macrophage depletion hinders
implantation
Care et al. (22)
Support luteal vascular network needed for
progesterone production
Progesterone supplementation rescues the
implantation phenotype of mice devoid of
CD11b macrophages
Care et al. (22)
Neutrophils Support of angiogenesis Uterine neutrophils produce VEGF Smith et al. (46)
Second-trimester neutrophils secrete
angiogeneic factors under the influence of
decidial-like environment
Amsalem et al. (47)
Dendritic cells Preparation of the uterus for implantation DC presence and clustering during the sexual
receptive phase
Zenclussen et al. (12)
Early antigen presentation to T cells and Tregs Presence of DCs in vaginal lumen attracted by
seminal fluid
Zenclussen et al. (49)
Sharkey et al. (21)
Support decidual transformation DC depletion impaired decidual proliferation
and decidualization
Plaks et al. (23)
Mediators of the communication between
trophoblasts and Tregs
DCs that were activated by trophoblasts
promote de conversion from naïve into Treg
cells
Du et al. (56)
Uterine mast cells Promote angiogenesis at the feto-maternal
interface
MCs degranulation had positive effect on
cervical angiogenesis
Bosquiazzo et al. (65)
Support implantation Uterine MCs secrete VEGF Varayoud et al. (70)
Positively influence tissue remodeling MC-deficient ckit knockout mice have
impaired implantation; reconstitution with
BMMCs can correct this
Woidacki et al. (13)
Modulate the remodeling of spiral arteries Transfer of MCs into MC-deficient mice was
related to increased TGFbeta/CtGF
Woidacki et al. (13)
Support fetal growth MC-deficient mice presented badly remodeled
spiral arteries and this could be rescue by MCs
Woidacki et al. (13)
MC-deficient animals presented smaller
fetuses and this could be corrected but wild
type but not Gal-1 deficient MC transfer
Woidacki et al. (13)
Uterine natural killer cells Important for the remodeling of spiral arteries Initiate the remodeling of spiral arteries, this is
mediated by IFNgamma
Ashkar et al. (78)
Promote angiogenesis at the feto-maternal
interface
In vivo, CO treatment provoked the in situ
expansion of uNKs and VEGF secretion
Greenwood et al. (80)
Linzke et al. (81)
ADAPTIVE IMMUNE CELLS
Regulatory T cells Preparation of the uterus for pregnancy Tregs accumulation at murine sexual
receptivity in the uterus
Teles et al. (6)
Early tolerance of paternal antigens expressed
in the fetus
Upon attraction by seminal fluid, Treg are
expanded by paternal antigens
Guerin et al. (92)
Contribute to a friendly uterine environment
that ensures implantation
Specific depletion of Foxp3+ Treg leads to
inflamed and fibrosed tissue that hinders
implantation
Teles et al. (6)
Essential for implantation Depletion of CD25+ cells impaired
implantation
Shima et al. (3)
Depletion of Foxp3+ cells hindered
implantation
Teles et al. (6)
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expanded population of Tregs within the uterine lymph nodes
and in the uterus as early as day 2 of pregnancy (86, 100, 101).
In addition, the transfer of Tregs before implantation can rescue
the fetuses from immunological rejection in the CBA/JDBA/2J
combination, while later transfer has no effect (2). Furthermore, it
seems that already at this early time point, antigen-specific Tregs
are needed; the adoptive transfer of Tregs isolated from non-
pregnant or unrelated pregnant females have no protective effect
(102). In the same line, it was showed that depletion of Tregs with
an anti-CD25 antibody at the post-implantation period does not
jeopardize pregnancy (3). Althoughmany studies show a defective
expansion of Treg in the periphery of women suffering from early
abortions, it appears more relevant to study their abundance in
the uterus in women that are able to get but not stay pregnant.
Whether the frequency of uterine Tregs can be deduced from
blood testing is yet not known and merits further studies.
Conclusion and Open Questions
Cells of the innate immune system are normally present in the
uterus. Some of them fluctuate in numbers as a consequence
of hormonal changes at different phases of the estrous cycle
in rodents and menstrual cycle in women. Depletion of DCs,
macrophages, and the absence of MCs results in implantation
failure. The studies outlined above suggest that they are involved
in the preparation of the uterus for pregnancy and contribute
to peri-implantation through secretion of cytokines, modulatory
molecules, and angiogeneic factors. Moreover, these cells appear
also to be also relevant for tissue remodeling and for supporting
the correct shaping of spiral arteries. It is also tempting to specu-
late that they have multiple functions at different time points and
that they adapt to the changes of the environment by secreting
different mediators. As the immune system has evolved about 500
million years ago and is, therefore, much older than placentation,
which dates back from about 150 million years ago, it is possible
that maternal immune cells present in the pregnant uterus have
adapted in order to mediate tissue homeostasis and to support
implantation. Many of the concepts arisen from animal studies
have to be interpreted with caution because they are based on
depletion of the respective innate cell populations. For exam-
ple, depletion of DCs in CD11c.DTR mice completely prevents
implantation (23), at first sight indicating an indispensable role for
DCs in pregnancy. No studies were performed to study fertility
in two independently derived strains of CD11c.DTA mice that
express the diphtheria toxin A chain under control of the CD11c
promoter and therefore lack DCs from birth on (58, 103). The
authors report that pups are apparently born at normal mendelian
rates; however, this is no guarantee for optimal fertility or preg-
nancy. Subfertility can imply a longer time period needed until
the female gets pregnant and suboptimal implantation or pla-
centation can lead to IUGR with serious implications for fetal
development. This cannot be predicted just by observing that
female mothers give birth to pups in normal mendelian rates. In
these mice that are constitutively devoid of DCs, a major effect
as observed when depleting DCs (23) can be however excluded,
otherwise there would be no living pups. It is evolutionarily highly
unlikely that other cell types can compensate for the absence of
DCs; however, in their absence, other cells may secrete the factors
that DCs normally secrete and so guarantee the development of
the optimal uterine environment for implantation. The apparent
discrepancy to the conditional DC depletion in CD11c.DTRmice
can probably be best explained by a perturbation of tissue and
cytokine balance in the uterus caused by the sudden removal of
DCs. Whether one single type of cell or a combination of cells, or
the molecules they secrete are indispensable for pregnancy is not
yet known. The special phenotype and functional characteristics
of uNK cells argues for an important role of uNK cell. No studies
are available with mice that lack exclusively uNK cells. The same
is true for uMCs. The recently generated CreMaster mice, which
are reportedly specifically deficient for MC cells (104) and also
lack uMCs (unpublished observations) were also not studied for
their fertility. However, independent of the question whether or
not particular innate cells are indispensable for pregnancy, the
clinically important aspect that emerges from these studies is that
perturbations in the uterus, e.g., by removal of a particular cell
population, greatly affect the establishment of pregnancy.
As for cells of the adaptive immune system, Tregs emerge as the
relevant T cell subset for conditioning the uterus for the blastocyst
to implant. Their depletion results in a hostile environment that
impedes normal placentation. Since the outcome of pregnancy
in T cell deficient RAG mutant mice is not as dramatic as it is
if depleting Tregs before mating, it seems that effector T cells
are the major targets and that uterine Tregs serve to prevent
excessive activation of T cells and production of inflammatory
cytokines that would lead to dangerous perturbation of uterine
tissue homeostasis. Interestingly, infertile women present low
levels of Tregs. Moreover, the uterine environment is negatively
FIGURE 1 | Cells of the innate and adaptive immune system present in
the uterus at the time of implantation. This cartoon graphically depicts the
abundance of immune cells and their close proximity with the invading
trophoblast. Uterine DCs (uDCs) are localized close to vessels and in
proximity to regulatory T cells (Treg). They act as mediators between Tregs
and trophoblasts; they support angiogenesis and are responsible for early
antigen presentation. Treg in turn are essential for preparing the uterus for
implantation; they are responsible for early tolerance toward paternal
antigens. Macrophages actively communicate with trophoblasts and support
the luteal vascular network. Uterine natural killer cells (uNK cells) are important
for tissue remodeling, to promote angiogenesis, and to contribute to the
shaping of spiral arteries. Neutrophils and uterine mast cells (uMCs) both
support angiogenesis. uMCs also modulate the remodeling of spiral arteries.
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modified in women that suffer from subclinical infections, e.g.,
with Chlamydia sp., which may explain why they fail to become
or stay pregnant. The histological modifications of the tissue spec-
imens frommice infected with Chlamydia show the same features
as those observed after Treg depletion, namely an inflamed tissue
with signs of fibrosis. More clinical data are needed to understand
whether changes in cells of the adaptive immune system are
related with infertility.
We have summarized the available information on the possible
role of immune cells for early pregnancy in Table 1. In Figure 1,
a cartoon intends to graphically depict the abundance of immune
cells and their close proximity with the invading trophoblast.
An unperturbed state of immune cell populations in the uterus
during early pregnancy is of importance not only for implantation
success but also for the quality of placentation. It is known that an
inadequate immune response at the onset of pregnancy can result
in shallow implantation and poor placentation, which can end in
miscarriage, IUGR, or pre-eclampsia. Further, impaired growth
in utero is implied in the development of metabolic diseases that
affect the health of the offspring.
While much information is already available to foster our
understanding of the complex circuit of immune cell interactions
that supports early pregnancy success, more studies are necessary
to understand this interplay in a holistic way. Approaches from
system biology may contribute to this field in the future. There
are still many open questions that we need to unravel in the future.
Due to the increased number of pregnancies after assisted repro-
ductive technologies, we need to understand how to interfere in
order to support the generation of the optimal microenvironment
for the blastocyst to attach. It is also very important to understand
which fetal structures are crucial for the generation of tolerance.
As pregnancies with fully foreign fetal antigens in egg donation
procedures and surrogate mothers are possible, it is conceivable
that fetal antigens are shed at a very early stage and contribute
to the generation of tolerance. It is also theoretically possible that
owing to the bidirectional chimerism fetal cells reach thematernal
circulation of surrogate mothers in egg donation pregnancies,
and this has an impact in later life, e.g., for the development
of autoimmune diseases because of strong antigenicity of the
fetus that is not only half foreign as it is in nature but also full
foreign. These and many other open questions should be our
challenge for the future and understanding the participation of
immune cells at early pregnancy is fundamental for unraveling
peri-implantation.
References
1. Tafuri A, Alferink J, Möller P, Hämmerling GJ, Arnold B. T cell awareness
of paternal alloantigens during pregnancy. Science (1995) 270:630–3. doi:10.
1126/science.270.5236.630
2. Zenclussen AC, Gerlof K, Zenclussen ML, Sollwedel A, Bertoja AZ, Ritter
T, et al. Abnormal T cell reactivity against paternal antigens in spontaneous
abortion: adoptive transfer of pregnancy-induced CD4+CD25+ T regulatory
cells prevents fetal rejection in a murine abortion model. Am J Pathol (2005)
166:811–22. doi:10.1016/S0002-9440(10)62302-4
3. Shima T, Sasaki Y, ItohM,NakashimaA, Ishii N, Sugamura K, et al. Regulatory
T cells are necessary for implantation and maintenance of early pregnancy
but not late pregnancy in allogeneic mice. J Reprod Immunol (2010) 85:121–9.
doi:10.1016/j.jri.2010.02.006
4. Samstein RM, Josefowicz SZ, Arvey A, Treuting PM, Rudensky AY.
Extrathymic generation of regulatory T cells in placental mammals mitigates
maternal-fetal conflict. Cell (2012) 150:29–38. doi:10.1016/j.cell.2012.05.031
5. Mold JE, Venkatasubrahmanyam S, Burt TD, Michaëlsson J, Rivera JM, Galk-
ina SA, et al. Fetal and adult hematopoietic stem cells give rise to distinct T cell
lineages in humans. Science (2010) 330:1695–9. doi:10.1126/science.1196509
6. Teles A, Schumacher A, Kühnle MC, Linzke N, Thuere C, Reichardt P, et al.
Control of uterine microenvironment by foxp3(+) cells facilitates embryo
implantation. Front Immunol (2013) 4:158. doi:10.3389/fimmu.2013.00158
7. Jasper MJ, Tremellen KP, Robertson SA. Primary unexplained infertility is
associatedwith reduced expression of the T-regulatory cell transcription factor
Foxp3 in endometrial tissue. Mol Hum Reprod (2006) 12:301–8. doi:10.1093/
molehr/gal032
8. Pijnenborg R, Robertson WB, Brosens I, Dixon G. Review article: trophoblast
invasion and the establishment of haemochorial placentation inman and labo-
ratory animals. Placenta (1981) 2:71–91. doi:10.1016/S0143-4004(81)80042-2
9. Rätsep MT, Felker AM, Kay VR, Tolusso L, Hofmann AP, Croy BA. Uterine
natural killer cells: supervisors of vasculature construction in early decidua
basalis. Reproduction (2015) 149:R91–102. doi:10.1530/REP-14-0271
10. Kämmerer U, Eggert AO, KappM,McLellan AD, Geijtenbeek TB, Dietl J, et al.
Unique appearance of proliferating antigen-presenting cells expressing DC-
SIGN (CD209) in the decidua of early human pregnancy. Am J Pathol (2003)
162:887–96. doi:10.1016/S0002-9440(10)63884-9
11. Blois SM, Alba Soto CD, Tometten M, Klapp BF, Margni RA, Arck PC.
Lineage, maturity, and phenotype of uterinemurine dendritic cells throughout
gestation indicate a protective role in maintaining pregnancy. Biol Reprod
(2004) 70:1018–23. doi:10.1095/biolreprod.103.022640
12. Zenclussen AC, Olivieri DN, Dustin ML, Tadokoro CE. In vivo multiphoton
microscopy technique to reveal the physiology of the mouse uterus. Am J
Reprod Immunol (2013) 69:281–9. doi:10.1111/aji.12066
13. Woidacki K, Popovic M, Metz M, Schumacher A, Linzke N, Teles A, et al.
Mast cells rescue implantation defects caused by c-kit deficiency. Cell Death
Dis (2013) 4:e462. doi:10.1038/cddis.2012.214
14. Schmerse F, Woidacki K, Riek-Burchardt M, Reichardt P, Roers A, Tadokoro
C, et al. In vivo visualization of uterine mast cells by two-photon microscopy.
Reproduction (2014) 147:781–8. doi:10.1530/REP-13-0570
15. Fest S, Aldo PB, Abrahams VM, Visintin I, Alvero A, Chen R, et al.
Trophoblast-macrophage interactions: a regulatory network for the protec-
tion of pregnancy. Am J Reprod Immunol (2007) 57:55–66. doi:10.1111/j.
1600-0897.2006.00446.x
16. King A, Jokhi PP, Burrows TD, Gardner L, Sharkey AM, Loke YW. Functions
of human decidual NK cells. Am J Reprod Immunol (1996) 35:258–60. doi:10.
1111/j.1600-0897.1996.tb00041.x
17. De M, Wood GW. Influence of oestrogen and progesterone on macrophage
distribution in themouse uterus. J Endocrinol (1990) 126:417–24. doi:10.1677/
joe.0.1260417
18. Schumacher A, Costa SD, Zenclussen AC. Endocrine factors modulating
immune responses in pregnancy. Front Immunol (2014) 5:196. doi:10.3389/
fimmu.2014.00196
19. Jensen F, Woudwyk M, Teles A, Woidacki K, Taran F, Costa S, et al. Estradiol
and progesterone regulate the migration of mast cells from the periphery to
the uterus and induce their maturation and degranulation. PLoS One (2010)
5:e14409. doi:10.1371/journal.pone.0014409
20. O’Leary S, Jasper MJ, Robertson SA, Armstrong DT. Seminal plasma regu-
lates ovarian progesterone production, leukocyte recruitment and follicular
cell responses in the pig. Reproduction (2006) 132:147–58. doi:10.1530/rep.1.
01119
21. Sharkey DJ, Tremellen KP, Jasper MJ, Gemzell-Danielsson K, Robertson SA.
Seminal fluid induces leukocyte recruitment and cytokine and chemokine
mRNA expression in the human cervix after coitus. J Immunol (2012)
188:2445–54. doi:10.4049/jimmunol.1102736
22. Care AS, Diener KR, Jasper MJ, Brown HM, Ingman WV, Robertson SA.
Macrophages regulate corpus luteum development during embryo implanta-
tion in mice. J Clin Invest (2013) 123:3472–87. doi:10.1172/JCI60561
Frontiers in Immunology | www.frontiersin.org June 2015 | Volume 6 | Article 3219
Zenclussen and Hämmerling Immune cells at implantation
23. Plaks V, Birnberg T, Berkutzki T, Sela S, BenYashar A, Kalchenko V, et al.
Uterine DCs are crucial for decidua formation during embryo implantation in
mice. J Clin Invest (2008) 118:3954–65. doi:10.1172/JCI36682
24. Serke H, Nowicki M, Kosacka J, Schröder T, Klöting N, Blüher M. Leptin-
deficient (ob/ob) mouse ovaries show fatty degeneration, enhanced apoptosis
and decreased expression of steroidogenic acute regulatory enzyme. Int J Obes
(Lond) (2012) 36:1047–53. doi:10.1038/ijo.2011.220
25. Parker VJ, Solano ME, Arck PC, Douglas AJ. Diet-induced obesity may affect
the uterine immune environment in early-mid pregnancy, reducing NK-
cell activity and potentially compromising uterine vascularization. Int J Obes
(Lond) (2014) 38:766–74. doi:10.1038/ijo.2013.164
26. Bellver J, Pellicer A, García-Velasco JA, Ballesteros A, Remohí J, Meseguer M.
Obesity reduces uterine receptivity: clinical experience from 9,587 first cycles
of ovum donation with normal weight donors. Fertil Steril (2013) 100:1050–8.
doi:10.1016/j.fertnstert.2013.06.001
27. Kim ST, Marquard K, Stephens S, Louden E, Allsworth J, Moley KH.
Adiponectin and adiponectin receptors in the mouse preimplantation embryo
and uterus. Hum Reprod (2011) 26:82–95. doi:10.1093/humrep/deq292
28. Hunt JS, Pollard JW. Macrophages in the uterus and placenta. Curr Top
Microbiol Immunol (1992) 181:39–63.
29. Robertson SA, Mau VJ, Tremellen KP, Seamark RF. Role of high molec-
ular weight seminal vesicle proteins in eliciting the uterine inflammatory
response to semen in mice. J Reprod Fertil (1996) 107:265–77. doi:10.1530/
jrf.0.1070265
30. Lambropoulou M, Tamiolakis D, Venizelos J, Liberis V, Galazios G, Tsikouras
P, et al. Imbalance of mononuclear cell infiltrates in the placental tissue from
foetuses after spontaneous abortion versus therapeutic termination from 8th
to 12th weeks of gestational age. Clin Exp Med (2006) 6:171–6. doi:10.1007/
s10238-006-0111-x
31. Petroff MG, Sedlmayr P, Azzola D, Hunt JS. Decidual macrophages are poten-
tially susceptible to inhibition by class Ia and class Ib HLAmolecules. J Reprod
Immunol (2002) 56:3–17. doi:10.1016/S0165-0378(02)00024-4
32. Heikkinen J, Möttönen M, Komi J, Alanen A, Lassila O. Phenotypic char-
acterization of human decidual macrophages. Clin Exp Immunol (2003)
131:498–505. doi:10.1046/j.1365-2249.2003.02092.x
33. McIntire RH, Hunt JS. Antigen presenting cells and HLA-G – a review.
Placenta (2005) 26:104–9. doi:10.1016/j.placenta.2005.01.006
34. Renaud SJ, Graham CH. The role of macrophages in utero-placental inter-
actions during normal and pathological pregnancy. Immunol Invest (2008)
37:535–64. doi:10.1080/08820130802191375
35. Chen JR, Cheng JG, Shatzer T, Sewell L, Hernandez L, Stewart CL. Leukemia
inhibitory factor can substitute for nidatory estrogen and is essential to
inducing a receptive uterus for implantation but is not essential for subse-
quent embryogenesis. Endocrinology (2000) 141:4365–72. doi:10.1210/en.141.
12.4365
36. Schofield G, Kimber SJ. Leukocyte subpopulations in the uteri of leukemia
inhibitory factor knockout mice during early pregnancy. Biol Reprod (2005)
72:872–8. doi:10.1095/biolreprod.104.034876
37. Helige C, Ahammer H, Moser G, Hammer A, Dohr G, Huppertz B, et al.
Distribution of decidual natural killer cells andmacrophages in the neighbour-
hood of the trophoblast invasion front: a quantitative evaluation.Hum Reprod
(2014) 29:8–17. doi:10.1093/humrep/det353
38. Huang SJ, Zenclussen AC, Chen CP, Basar M, Yang H, Arcuri F, et al. The
implication of aberrant GM-CSF expression in decidual cells in the pathogene-
sis of preeclampsia.Am J Pathol (2010) 177:2472–82. doi:10.2353/ajpath.2010.
091247
39. Jensen AL, Collins J, Shipman EP, Wira CR, Guyre PM, Pioli PA. A subset
of human uterine endometrial macrophages is alternatively activated. Am J
Reprod Immunol (2012) 68:374–86. doi:10.1111/j.1600-0897.2012.01181.x
40. Siwetz M, Sundl M, Kolb D, Hiden U, Herse F, Huppertz B, et al. Placental
fractalkine mediates adhesion of THP-1 monocytes to villous trophoblast.
Histochem Cell Biol (2015) 143(6):565–74. doi:10.1007/s00418-014-1304-0
41. Szukiewicz D, Kochanowski J, Mittal TK, Pyzlak M, Szewczyk G, Cendrowski
K. Chorioamnionitis (ChA) modifies CX3CL1 (fractalkine) production by
human amniotic epithelial cells (HAEC) under normoxic and hypoxic con-
ditions. J Inflamm (Lond) (2014) 11:12. doi:10.1186/1476-9255-11-12
42. Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli
L. Neutrophils: molecules, functions and pathophysiological aspects. Lab
Invest (2000) 80:617–53. doi:10.1038/labinvest.3780067
43. Benelli R, Morini M, Carrozzino F, Ferrari N, Minghelli S, Santi L, et al.
Neutrophils as a key cellular target for angiostatin: implications for regulation
of angiogenesis and inflammation. FASEB J (2002) 16:267–9. doi:10.1096/fj.
01-0651fje
44. Porta C, Subhra Kumar B, Larghi P, Rubino L, Mancino A, Sica A. Tumor
promotion by tumor-associated macrophages. Adv Exp Med Biol (2007)
604:67–86.
45. Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L, et al. Polarization of
tumor-associated neutrophil phenotype by TGF-beta: “N1” versus “N2” TAN.
Cancer Cell (2009) 16:183–94. doi:10.1016/j.ccr.2009.06.017
46. Smith JM, Wira CR, Fanger MW, Shen L. Human fallopiantube neutrophils –
a distinct phenotype from blood neutrophils. Am J Reprod Immunol (2006)
56:218–29. doi:10.1111/j.1600-0897.2006.00410.x
47. Amsalem H, Kwan M, Hazan A, Zhang J, Jones RL, Whittle W, et al. Iden-
tification of a novel neutrophil population: proangiogenic granulocytes in
second-trimester human decidua. J Immunol (2014) 193:3070–9. doi:10.4049/
jimmunol.1303117
48. Mizugishi K, Inoue T, Hatayama H, Bielawski J, Pierce JS, Sato Y, et al.
Sphingolipid pathway regulates innate immune responses at the fetomaternal
interface during pregnancy. J Biol Chem (2015) 290:2053–68. doi:10.1074/jbc.
M114.628867
49. Zenclussen ML, Thuere C, Ahmad N, Wafula PO, Fest S, Teles A, et al. The
persistence of paternal antigens in the maternal body is involved in regulatory
T-cell expansion and fetal-maternal tolerance in murine pregnancy. Am J
Reprod Immunol (2010) 63:200–8. doi:10.1111/j.1600-0897.2009.00793.x
50. Daikoku N, Kitaya K, Nakayama T, Fushiki S, Honjo H. Expression of
macrophage inflammatory protein-3beta in human endometrium throughout
the menstrual cycle. Fertil Steril (2004) 81:876–81. doi:10.1016/j.fertnstert.
2003.09.036
51. Robertson SA, Mayrhofer G, Seamark RF. Ovarian steroid hormones regu-
late granulocyte-macrophage colony-stimulating factor synthesis by uterine
epithelial cells in the mouse. Biol Reprod (1996) 54:183–96. doi:10.1095/
biolreprod54.1.183
52. Hsu P, Santner-Nanan B, Dahlstrom JE, Fadia M, Chandra A, Peek M, et al.
Altered decidual DC-SIGN+ antigen-presenting cells and impaired regulatory
T-cell induction in preeclampsia. Am J Pathol (2012) 181:2149–60. doi:10.
1016/j.ajpath.2012.08.032
53. Schumacher A, Wafula PO, Teles A, El-Mousleh T, Linzke N, Zenclussen
ML, et al. Blockage of heme oxygenase-1 abrogates the protective effect
of regulatory T cells on murine pregnancy and promotes the maturation
of dendritic cells. PLoS One (2012) 7:e42301. doi:10.1371/journal.pone.
0042301
54. Schumacher A, Heinze K, Witte J, Poloski E, Linzke N, Woidacki K, et al.
Human chorionic gonadotropin as a central regulator of pregnancy immune
tolerance. J Immunol (2013) 190:2650–8. doi:10.4049/jimmunol.1202698
55. Moldenhauer LM, Keenihan SN, Hayball JD, Robertson SA. GM-CSF is an
essential regulator of T cell activation competence in uterine dendritic cells
during early pregnancy in mice. J Immunol (2010) 185:7085–96. doi:10.4049/
jimmunol.1001374
56. Du MR, Guo PF, Piao HL, Wang SC, Sun C, Jin LP, et al. Embryonic tro-
phoblasts induce decidual regulatory T cell differentiation and maternal-fetal
tolerance through thymic stromal lymphopoietin instructing dendritic cells. J
Immunol (2014) 192:1502–11. doi:10.4049/jimmunol.1203425
57. Negishi Y, Wakabayashi A, Shimizu M, Ichikawa T, Kumagai Y, Takeshita
T, et al. Disruption of maternal immune balance maintained by innate DC
subsets results in spontaneous pregnancy loss in mice. Immunobiology (2012)
217:951–61. doi:10.1016/j.imbio.2012.01.011
58. Birnberg T, Bar-On L, Sapoznikov A, CatonML, Cervantes-Barragán L,Makia
D, et al. Lack of conventional dendritic cells is compatible with normal devel-
opment and T cell homeostasis, but causes myeloid proliferative syndrome.
Immunity (2008) 19:986–97. doi:10.1016/j.immuni.2008.10.012
59. Rieger L, Honig A, Sütterlin M, Kapp M, Dietl J, Ruck P, et al. Antigen-
presenting cells in human endometrium during themenstrual cycle compared
to early pregnancy. J Soc Gynecol Investig (2004) 11:488–93. doi:10.1016/j.jsgi.
2004.05.007
60. Gardner L,Moffett A.Dendritic cells in the human decidua.Biol Reprod (2003)
69:1438–46. doi:10.1095/biolreprod.103.017574
61. Amodio G, Mugione A, Sanchez AM, Viganò P, Candiani M, Somigliana E,
et al. HLA-G expressing DC-10 and CD4(+) T cells accumulate in human
Frontiers in Immunology | www.frontiersin.org June 2015 | Volume 6 | Article 32110
Zenclussen and Hämmerling Immune cells at implantation
decidua during pregnancy. Hum Immunol (2013) 74:406–11. doi:10.1016/j.
humimm.2012.11.031
62. Tirado-González I, Muñoz-Fernández R, Blanco O, Leno-Durán E, Abadía-
Molina AC, Olivares EG. Reduced proportion of decidual DC-SIGN+ cells
in human spontaneous abortion. Placenta (2010) 31:1019–22. doi:10.1016/j.
placenta.2010.09.008
63. Bytautiene E, Vedernikov YP, Saade GR, Romero R, Garfield RE. IgE-
independent mast cell activation augments contractility of nonpregnant and
pregnant guinea pigmyometrium. Int ArchAllergy Immunol (2008) 147:140–6.
doi:10.1159/000135701
64. Norrby K. Mast cells and angiogenesis. APMIS (2002) 110:355–71. doi:10.
1034/j.1600-0463.2002.100501.x
65. Shelesnyak MC. Antihistamines and the ovum. Br Med J (1963) 16:1268.
doi:10.1136/bmj.2.5367.1268-a
66. Bosquiazzo VL, Ramos JG, Varayoud J, Muñoz-de-Toro M, Luque EH. Mast
cell degranulation in rat uterine cervix during pregnancy correlates with
expression of vascular endothelial growth factor mRNA and angiogenesis.
Reproduction (2007) 133:1045–55. doi:10.1530/REP-06-0168
67. Menzies FM, Higgins CA, Shepherd MC, Nibbs RJ, Nelson SM. Mast cells
reside in myometrium and cervix, but are dispensable in mice for successful
pregnancy and labor. Immunol Cell Biol (2012) 90:321–9. doi:10.1038/icb.
2011.40
68. Cocchiara R, Albeggiani G, Di Trapani G, Azzolina A, Lampiasi N, Rizzo F,
et al. Oestradiol enhances in vitro the histamine release induced by embry-
onic histamine-releasing factor (EHRF) from uterine mast cells. Hum Reprod
(1992) 7:1036–41.
69. Lyon MF, Glenister PH. A new allele sash (Wsh) at the W-locus and a
spontaneous recessive lethal inmice.Genet Res (1982) 39:315–22. doi:10.1017/
S001667230002098X
70. Valent P, Sillaber C, Baghestanian M, Bankl HC, Kiener HP, Lechner K,
et al. What have mast cells to do with edema formation, the consecutive
repair and fibrinolysis? Int Arch Allergy Immunol (1998) 115:2–8. doi:10.1159/
000023823
71. Varayoud J, Ramos JG, Bosquiazzo VL, Muñoz-de-Toro M, Luque EH. Mast
cells degranulation affects angiogenesis in the rat uterine cervix during preg-
nancy. Reproduction (2004) 127:379–87. doi:10.1530/rep.1.00018
72. Hatta K, Carter AL, Chen Z, Leno-Durán E, Ruiz-Ruiz C, Olivares EG, et al.
Expression of the vasoactive proteins AT1, AT2, and ANP by pregnancy-
inducedmouse uterine natural killer cells.Reprod Sci (2011) 18:383–90. doi:10.
1177/1933719110385136
73. Croy BA, Chen Z, Hofmann AP, Lord EM, Sedlacek AL, Gerber SA. Imaging
of vascular development in earlymouse decidua and its associationwith leuko-
cytes and trophoblasts.Biol Reprod (2012) 87:125. doi:10.1095/biolreprod.112.
102830
74. Croy BA, van den Heuvel MJ, Borzychowski AM, Tayade C. Uter-
ine natural killer cells: a specialized differentiation regulated by ovarian
hormones. Immunol Rev (2006) 214:161–85. doi:10.1111/j.1600-065X.2006.
00447.x
75. Paffaro VA, Bizinotto MC, Joazeiro PP, Yamada AT. Subset classification of
mouse uterine natural killer cells by DBA lectin reactivity. Placenta (2003)
24:479–88. doi:10.1053/plac.2002.0919
76. Wang C, Umesaki N, Nakamura H, Tanaka T, Nakatani K, Sakaguchi I, et al.
Expression of vascular endothelial growth factor by granulated metrial gland
cells in pregnant murine uteri. Cell Tissue Res (2000) 300:285–93. doi:10.1007/
s004410000198
77. Tayade C, Hilchie D, He H, Fang Y, Moons L, Carmeliet P, et al. Genetic
deletion of placenta growth factor in mice alters uterine NK cells. J Immunol
(2007) 178:4267–75. doi:10.4049/jimmunol.178.7.4267
78. Degaki KY, Chen Z, YamadaAT, Croy BA.Delta-like ligand (DLL)1 expression
in early mouse decidua and its localization to uterine natural killer cells. PLoS
One (2012) 7:e52037. doi:10.1371/journal.pone.0052037
79. Ashkar AA, Croy BA. Functions of uterine natural killer cells are mediated
by interferon gamma production during murine pregnancy. Semin Immunol
(2001) 13:235–41. doi:10.1006/smim.2000.0319
80. Greenwood JD,Minhas K, di Santo JP, Makita M, Kiso Y, Croy BA. Ultrastruc-
tural studies of implantation sites from mice deficient in uterine natural killer
cells. Placenta (2000) 21:693–702. doi:10.1053/plac.2000.0556
81. Bilinski MJ, Thorne JG, OhMJ, Leonard S, Murrant C, Tayade C, et al. Uterine
NK cells in murine pregnancy. Reprod Biomed Online (2008) 16:218–26.
doi:10.1016/S1472-6483(10)60577-9
82. Linzke N, Schumacher A, Woidacki K, Croy BA, Zenclussen AC. Carbon
monoxide promotes proliferation of uterine natural killer cells and remod-
eling of spiral arteries in pregnant hypertensive heme oxygenase-1 mutant
mice. Hypertension (2014) 63:580–8. doi:10.1161/HYPERTENSIONAHA.
113.02403
83. ZhaoH, Azuma J, Kalish F,Wong RJ, StevensonDK.Maternal heme oxygenase
1 regulates placental vasculature development via angiogenic factors in mice.
Biol Reprod (2011) 85:1005–12. doi:10.1095/biolreprod.111.093039
84. Redman CW, Sargent IL. Latest advances in understanding preeclampsia.
Science (2005) 308:1592–4. doi:10.1126/science.1111726
85. Fernandez N, Cooper J, Sprinks M, AbdElrahman M, Fiszer D, Kurpisz M,
et al. A critical review of the role of the major histocompatibility complex
in fertilization, preimplantation development and feto-maternal interactions.
Hum Reprod Update (1999) 5:234–48. doi:10.1093/humupd/5.3.234
86. Thuere C, Zenclussen ML, Schumacher A, Langwisch S, Schulte-Wrede U,
Teles A, et al. Kinetics of regulatory T cells during murine pregnancy. Am J
Reprod Immunol (2007) 58:514–23. doi:10.1111/j.1600-0897.2007.00538.x
87. Tilburgs T, Scherjon SA, van der Mast BJ, Haasnoot GW, Versteeg-V D,
Voort-MaarschalkM, et al. Fetal-maternalHLA-Cmismatch is associatedwith
decidual T cell activation and induction of functional T regulatory cells. J
Reprod Immunol (2009) 82:148–57. doi:10.1016/j.jri.2009.05.003
88. Rolle L, Memarzadeh Tehran M, Morell-García A, Raeva Y, Schumacher A,
Hartig R, et al. Cutting edge: IL-10-producing regulatory B cells in early human
pregnancy. Am J Reprod Immunol (2013) 70:448–53. doi:10.1111/aji.12157
89. Jensen F, Muzzio D, Soldati R, Fest S, Zenclussen AC. Regulatory B10 cells
restore pregnancy tolerance in a mouse model. Biol Reprod (2013) 89:90.
doi:10.1095/biolreprod.113.110791
90. Fettke F, Schumacher A, Costa SD, Zenclussen AC. B cells: the old new
players in reproductive immunology. Front Immunol (2014) 5:285. doi:10.
3389/fimmu.2014.00285
91. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-
tolerance maintained by activated T cells expressing IL-2 receptor α-chains
(CD25). Breakdown of a single mechanism of self-tolerance causes various
autoimmune diseases. J Immunol (1995) 155:1151–64.
92. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal
tolerance to the fetus. Nat Immunol (2004) 5:266–71. doi:10.1038/ni1037
93. Guerin LR, Moldenhauer LM, Prins JR, Bromfield JJ, Hayball JD, Robertson
SA. Seminal fluid regulates accumulation of FOXP3+ regulatory T cells in the
preimplantation mouse uterus through expanding the FOXP3+ cell pool and
CCL19-mediated recruitment. Biol Reprod (2011) 85:397–408. doi:10.1095/
biolreprod.110.088591
94. Kim JM, Rasmussen JP, Rudensky AY. Regulatory T cells prevent catastrophic
autoimmunity throughout the lifespan of mice. Nat Immunol (2007) 8:191–7.
doi:10.1038/ni1428
95. Suffner J, Hochweller K, Kühnle MC, Li X, Kroczek RA, Garbi N, et al.
Dendritic cells support homeostatic expansion of Foxp3+ regulatory T cells in
Foxp3.LuciDTRmice. J Immunol (2010) 184:1810–20. doi:10.4049/jimmunol.
0902420
96. He Q, Tsang LL, Ajonuma LC, Chan HC. Abnormally up-regulated cystic
fibrosis transmembrane conductance regulator expression and uterine fluid
accumulation contribute to Chlamydia trachomatis-induced female infertility.
Fertil Steril (2010) 93:2608–14. doi:10.1016/j.fertnstert.2010.01.040
97. Shah AA, Schripsema JH, Imtiaz MT, Sigar IM, Kasimos J, Matos PG, et al.
Histopathologic changes related to fibrotic oviduct occlusion after genital
tract infection of mice with Chlamydia muridarum. Sex Transm Dis (2005)
32:49–56. doi:10.1097/01.olq.0000148299.14513.11
98. Zenclussen ML, Casalis PA, El-Mousleh T, Rebelo S, Langwisch S, Linzke N,
et al. Haem oxygenase-1 dictates intrauterine fetal survival in mice via carbon
monoxide. J Pathol (2011) 225:293–304. doi:10.1002/path.2946
99. Nancy P, Tagliani E, Tay CS, Asp P, Levy DE, Erlebacher A. Chemokine gene
silencing in decidual stromal cells limits T cell access to the maternal-fetal
interface. Science (2012) 336:1317–21. doi:10.1126/science.1220030
100. Zhao JX, Zeng YY, Liu Y. Fetal alloantigen is responsible for the expansion
of the CD4(+)CD25(+) regulatory T cell pool during pregnancy. J Reprod
Immunol (2007) 75:71–81. doi:10.1016/j.jri.2007.06.052
101. Robertson SA, Guerin LR, Moldenhauer LM, Hayball JD. Activating T regula-
tory cells for tolerance in early pregnancy – the contribution of seminal fluid.
J Reprod Immunol (2009) 83:109–16. doi:10.1016/j.jri.2009.08.003
102. Schumacher A, Wafula PO, Bertoja AZ, Sollwedel A, Thuere C, Wollenberg I,
et al. Mechanisms of action of regulatory T cells specific for paternal antigens
Frontiers in Immunology | www.frontiersin.org June 2015 | Volume 6 | Article 32111
Zenclussen and Hämmerling Immune cells at implantation
during pregnancy. Obstet Gynecol (2007) 110:1137–45. doi:10.1097/01.AOG.
0000284625.10175.31
103. Ohnmacht C, Pullner A, King SB, Drexler I, Meier S, Brocker T, et al. Con-
stitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and
results in spontaneous fatal autoimmunity. J Exp Med (2009) 206(3):549–59.
doi:10.1084/jem.20082394
104. Feyerabend TB, Weiser A, Tietz A, Stassen M, Harris N, Kopf M, et al.
Cre-mediated cell ablation contests mast cell contribution in models of
antibody- and T cell-mediated autoimmunity. Immunity (2011) 35(5):832–44.
doi:10.1016/j.immuni.2011.09.015
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.
Copyright © 2015 Zenclussen and Hämmerling. This is an open-access article dis-
tributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Immunology | www.frontiersin.org June 2015 | Volume 6 | Article 32112
